BETA DRUGS
|
The Current P/S Ratio of BETA DRUGS is 6.31.
| Share Price | ₹2,314.7 | Jul 22,2026 |
| Market Cap | ₹2,569.3 Cr | |
| Sales-TTM | ₹407.0 Cr | TTM-Consolidated Results |
| Price/Sales | 6.31x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BETA DRUGS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,569.3 Cr] as on Jul 22,2026
(/) Sales [ ₹407.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 6.31x ]
Thus, for BETA DRUGS , the investors are currently willing to pay '6.31 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BETA DRUGS !
The chart below summarizes the trend in P/S Ratio of BETA DRUGS over the last five years.
Historical PS (Price/Sales) ratio chart of BETA DRUGS
PS Ratio Performance Analysis for BETA DRUGS
- BETA DRUGS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.18x.
- BETA DRUGS 's operated at median p/e ratio of 2.96x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BETA DRUGS 's p/e ratio peaked in Mar2025 at 5.31x.
- BETA DRUGS 's p/e ratio hit its five-year low in Mar2021 of 0.99x.
How does BETA DRUGS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BETA DRUGS | 407.0 | 6.31 | 2,569.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.97 | 466,179.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 18.57 | 196,095.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 13.70 | 191,530.0 |
| CIPLA LTD | 28,162.6 | 4.06 | 114,318.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.97 | 98,742.1 |
| MANKIND PHARMA LTD | 14,277.6 | 7.36 | 105,068.0 |
| LUPIN LTD | 27,958.0 | 3.93 | 110,002.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.15 | 112,693.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.62 | 88,202.5 |
| LAURUS LABS LTD | 6,812.9 | 12.51 | 85,232.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BETA DRUGS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.62x |
| Max industry PS | 18.57x |
| Median industry PS | 6.31x |
| Average industry PS | 7.65x |
You may also like the below Video Courses